A rat model for neural circuitry abnormalities in schizophrenia

Nature Protocols

Volumn 1, Issue 2, 2006, Pages 833-839

  Berretta, Sabina ^a,b   Benes, Francine M ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MCLEAN HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR BLOCKING AGENT; PICROTOXIN;

ANIMAL; ARTICLE; CHEMICALLY INDUCED DISORDER; CYTOLOGY; DISEASE MODEL; DRUG EFFECT; HIPPOCAMPUS; METABOLISM; NERVE CELL; PATHOLOGY; PATHOPHYSIOLOGY; RAT; SCHIZOPHRENIA; SPRAGUE DAWLEY RAT;

ANIMALS; DISEASE MODELS, ANIMAL; GABA ANTAGONISTS; HIPPOCAMPUS; NEURONS; PICROTOXIN; RATS; RATS, SPRAGUE-DAWLEY; SCHIZOPHRENIA;

EID: 33947313796     PISSN: 17542189     EISSN: 17502799     Source Type: Journal    
DOI: 10.1038/nprot.2006.110     Document Type: Article

References (59)

1. Benes, F.M. & Berretta, S. GABAergic interneurons: Implications for understanding schizophrenia and bipolar disorder. Neuropsychopharmacology 25, 1-27 (2001).
2. Lipska, B.K. & Weinberger, D.R. To model a psychiatric disorder in animals: Schizophrenia as a reality test. Neuropsychopharmacology 23, 223-239 (2000).
3. Shekhar, A., Sajdyk, T.J., Gehlert, D.R. & Rainnie, D.G. The amygdala, panic disorder, and cardiovascular responses. Ann. NY Acad. Sci. 985, 308-325 (2003).
4. Kilts, C.D. The changing roles and targets for animal models of schizophrenia. Biol. Psychiatry 50, 845-855 (2001).
5. Bogerts, B., Meertz, E. & Schonfeldt-Bausch, R. Basal ganglia and limbic system pathology in schizophrenia. Arch. Gen. Psychiatry 42, 748-791 (1985).
6. Yang, C.Q., Kitamura, N., Nishino, N., Shirakawa, O. & Nakai, H. Isotype-specific G protein abnormalities in the left superior temporal cortex and limbic structures of patients with chronic schizophrenia. Biol. Psychiatry 43, 12-19 (1998).
7. Lawrie, S.M. & Abukmeil, S.S. Brain abnormality in schizophrenia. A systematic and quantitative review of volumetric magnetic resonance imaging studies. Br J. Psychiatry 172, 110-120 (1998).
8. Marsh, L., Suddath, R.L., Higgins, N. & Weinberger, D.R. Medial temporal lobe structures in schizophrenia: Relationship of size to duration of illness. Schizophr. Res. 11, 225-238 (1994).
9. 0) in the medial temporal lobe in schizophrenia: Preliminary report of a neurochemical correlate of structural change. J. Neural Transm. Gen. Sect. 84, 147-153 (1991).
10. Reynolds, G.P., Czudek, C. & Andrews, H.B. Deficit and hemispheric asymmetry of GABA uptake sites in the hippocampus in schizophrenia. Biol. Psychiatry 27, 1038-1044 (1990).
11. Reynolds, G.P. Increased concentrations and lateral asymmetry of amygdala dopamine in schizophrenia. Nature 305, 527-529 (1983).
12. Breier, A. et al. Brain morphology and schizophrenia. A magnetic resonance imaging study of limbic, prefrontal cortex, and caudate structures. Arch. Gen. Psychiatry 49, 921-926 (1992).
13. Reynolds, G.P. in The Amygdala (ed. Aggleton, J.P) 561-574 (Wiley-Liss, New York, 1992).
14. Simpson, M.D.C. et al. Reduced GABA uptake sites in the temporal lobe in schizophrenia. Neurosci. Lett. 107, 211-215 (1989).
15. Gur, R.E. et al. Temporolimbic volume reductions in schizophrenia. Arch. Gen. Psychiatry 57, 769-775 (2000).
16. Schneider, F. et al. Differential amygdala activation in schizophrenia during sadness. Schizophr. Res. 34, 133-142 (1998).
17. Kosaka, H. et al. Differential amygdala response during facial recognition in patients with schizophrenia: An fMRI study. Schizophr. Res. 57, 87 (2002).
18. Williams, L.M. et al. Dysregulation of arousal and amygdala-prefrontal systems in paranoid schizophrenia. Am. J. Psychiatry 161, 480-489 (2004).
19. Perlman, W.R., Webster, M.J., Kleinman, J.E. & Weickert, C.S. Reduced glucocorticoid and estrogen receptor alpha messenger ribonucleic acid levels in the amygdala of patients with major mental illness. Biol. Psychiatry 56, 844-852 (2004).
20. Carletti, R., Corsi, M., Melotto, S. & Caberlotto, L. Down-regulation of amygdala preprotachykinin A mRNA but not 3H-SP receptor binding sites in subjects affected by mood disorders and schizophrenia. Eur. J. Neurosci. 21, 1712-1718 (2005).
21. Aleman, A. & Kahn, R.S. Strange feelings: Do amygdala abnormalities dysregulate the emotional brain in schizophrenia? Prog. Neurobiol. 77, 283-298 (2005).
22. Weidenhofer, J., Bowden, N.A., Scott, R.J. & Tooney, P.A. Altered gene expression in the amygdala in schizophrenia: Up-regulation of genes located in the cytomatrix active zone. Mol. Cell. Neurosci. 31 243-250 (2006).
23. Herringa, R.J., Roseboom, P.H. & Kalin, N.H. Decreased amygdala CRF-binding protein mRNA in post-mortem tissue from male but not female bipolar and schizophrenic subjects. Neuropsychopharmacology (2006) PMID: 16545343.
24. Holt, D.J. et al. Increased medial temporal lobe activation during the passive viewing of emotional and neutral facial expressions in schizophrenia. Schizophr. Res. 82, 153-162 (2006).
25. Korpi, E.R., Kleiman, J.E., Goodman, S.I. & Wyatt, R.J. Neurotransmitter amino acids in post-mortem brains of chronic schizophrenic patients. Psychiatry Res. 22, 291-301 (1987).
26. Akbarian, S. et al. Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics. Arch. Gen. Psychiatry 52, 258-266 (1995).
27. Bachus, S.E., Hyde, T.M., Herman, M.M., Egan, M.F. & Kleinman, J.E. Abnormal cholecystokinin mRNA levels in entorhinal cortex of schizophrenics. J. Psychiatr. Res. 31, 233-256 (1997).
28. Benes, F.M. Altered glutamatergic and GABAergic mechanisms in the cingulate cortex of the schizophrenic brain. Arch. Gen. Psychiatry 52, 1015-1018 (1995).
29. Beasley, C.L. & Reynolds, G.P. Parvalbumin-immunoreactive neurons are reduced in the prefrontal cortex of schizophrenics. Schizophr. Res. 24, 349-355 (1997).
30. Benes, F.M., Vincent, S.L., Marie, A. & Khan, Y. Up-regulation of GABAA receptor binding on neurons of the prefrontal cortex in schizophrenic subjects. Neuroscience 75, 1021-1031 (1996).
31. Benes, F.M., Vincent, S.L., Alsterberg, G., Bird, E.D. & SanGiovanni, J.P. Increased GABAA receptor binding in superficial layers of cingulate cortex in schizophrenics. J. Neurosci. 12, 924-929 (1992).
32. Benes, F.M., McSparren, J., Bird, E.D., SanGiovanni, J.P. & Vincent, S.L. Deficits in small interneurons in prefrontal and cingulate cortices of schizophrenic and schizoaffective patients. Arch. Gen. Psychiatry 48, 996-1001 (1991).
33. Woo, T.U., Whitehead, R.E., Melchitzky, D.S. & Lewis, D.A. A subclass of prefrontal gamma-aminobutyric acid axon terminals are selectively altered in schizophrenia. Proc. Natl. Acad. Sci. USA 95, 5341-5346 (1998).
34. Danos, P. et al. Schizophrenia and anteroventrat thalamic nucleus: selective decrease of parvalbumin-immunoreactive thalamocortical projection neurons. Psychiatry Res. 82, 1-10 (1998).
35. Benes, F.M., Wickramasinghe, R., Vincent, S.L., Khan, Y. & Todtenkopf, M. Uncoupling of GABA-A and benzodiazepine receptor binding activity in the hippocampal formation of schizophrenic brain. Brain Res. 755, 121-129 (1997).
36. Benes, F.M., Kwok, E.W. Vincent, S.L. & Todtenkopf, M.S. A reduction of nonpyramidal cells in sector CA2 of schizophrenics and manic depressive. Biol. Psychiatry 44, 88-97 (1998).
37. Todtenkopf, M.S. & Benes, F.M. Distribution of glutamate decarboxylase 65 immunoreactive puncta on pyramidal and nonpyramidal neurons in hippocampus of schizophrenic brain. Synapse 29, 323-332 (1998).
38. Woo, T.U., Walsh, J.P. & Benes, F.M. Density of glutamic acid decarboxylase 67 messenger RNA-containing neurons that express the N-methyl-D-aspartate receptor subunit NR2A in the anterior cingulate cortex in schizophrenia and bipolar disorder. Arch. Gen. Psychiatry 61, 649-657 (2004).
39. Pitkanen, A., Pikkarainen, M., Nurminen, N. & Ylinen, A. Reciprocal connections between the amygdala and the hippocampal formation, perirhinal cortex, and postrhinal cortex in rat A review. Ann. NY Acad. Sci. 911, 369-391 (2000).
40. Berretta, S., Munno, D.W. & Benes, F.M. Amygdalar activation alters the hippocampal GABA system: Partial modelling for postmortem changes in schizophrenia. J. Comp. Neurol. 431, 129-138 (2001).
41. Iritani, S., Kuroki, N., Ikeda, K. & Kazamatsuri, H. Calbindin immunoreactivity in the hippocampal formation and neocortex of schizophrenics. Prog. Neuropsychopharmacol. Biol. Psychiatry 23 409-421 (1999).
42. Zhang, Z.J. & Reynolds, G.P. A selective decrease in the relative density of parvalbumin-immunoreactive neurons in the hippocampus in schizophrenia. Schrizophr. Res. 55, 1-10 (2002).
43. Chebib, M. & Johnston, G.A. The'ABC' of GABA receptors: A brief review. Clin. Exp. Pharmacol. Physiol. 26, 937-940 (1999)
44. Danober, L. & Pape, H.C. Strychnine-sensitive glycine responses in neurons of the lateral amygdala: An electrophysiological and immunocytochemical characterization. Neuroscience 85, 427-441 (1998).
45. McCool, B.A. & Botting, S.K. Characterization of strychnine-sensitive glycine receptors in acutely isolated adult rat basolateral amygdala neurons. Brain Res. 859, 341-351 (2000).
46. McCool. B.A. & Farroni, J.S. Subunit composition of strychnine-sensitive glycine receptors expressed by adult rat basolateral amygdala neurons. Eur J. Neurosci. 14, 1082-1090 (2001).
47. Berretta, S. et al. Long-term effects of amygdala GABA receptor blockade on specific subpopulations of hippocampal interneurons. Hippocampus 14, 876-894 (2004).
48. Ikemoto, S., Murphy, J.M. & McBride, W.J. Self-infusion of GABA(A) antagonists directly into the ventral togmental area and adjacent regions. Behav. Neurosci. 111, 369-380 (1997).
49. Kodsi, M. H. & Swerdlow, N.R. Prepulse inhibition in the rat is regulated by ventral and caudodorsal striato-pallidal circuitry. Behav. Neurosci. 109, 912-928 (1995).
50. Berretta, S., Parthasarathy, H.P. & Graybiel, A.M. Local release of GABAergic inhibition in the motor cortex induces immediate-early gene expression in indirect pathway neurons of the striatum. J. Neurosci. 17, 4752-4763 (1997).
51. Benes, F.M. et al. Acute amygdalar activation induces an upregulation of multiple monoamine G protein coupled pathways in rat hippocampus. Mol. Psychiatry 9, 932-945 (2004).
52. Gisabella, B., Bolshakov, V.Y. & Benes, F.M. Regulation of synaptic plasticity in a schizophrenia model. Proc. Natl. Acad. Sci. USA 102, 13301-13306 (2005).
53. Cunningham, M.G., Bhattacharyya, S. & Benes, F.M. Post-natal ingrowth of amygdalo-cortical afferents in rat brain continues into adulthood. Soc. Neurosci. Abstracts - Annual Meeting Publication, 26 (2000).
54. Cunningham, M.G., Bhattacharyya, S. & Benes, F.M. Amygdalo-cortical sprouting continues into early adulthood: Implications for the development of normal and abnormal function during adolescence. J. Comp. Neurol. 453, 116-130 (2002).
55. Kraepelin, E. Dementia Praecox and Paraphrenia. (Chicago Medical Books, Chicago, 1919).
56. Cain, D.P. Kindling by repeated intraperitoneal or intracerebral injection of picrotoxin transfers to electrical kindling. Exp. Neurol. 97, 243-254 (1987).
57. Stevens, J.R. Epilepsy, schizophrenia, and the extended amygdala. Ann. NY Acad. Sci. 877, 548-561 (1999).
58. Benes, F.M., Khan, Y., Vincent, S.L. & Wickramasinghe, R. Differences in the subregional and cellular distribution of GABAA receptor binding in the hippocampal formation of schizophrenic brain. Synapse 22 338-349 (1996).
59. Benes, F.M., Wickramasinghe, R., Vincent S.L., Khan, Y. & Todtenkopf, M. Uncoupling of GABA(A) and benzodiazepine receptor binding activity in the hippocampal formation of schizophrenic brain. Brain Res. 755, 121-129 (1997).